U.S. Gas Utilities Stock News

NasdaqGS:DXPE
NasdaqGS:DXPETrade Distributors

DXP Enterprises (DXPE) Falls Before Earnings, Is The 6% Discount Enough?

DXP Enterprises (DXPE) shares declined 7.54% in the latest session, lagging the S&P 500 and industrial peers as investors focused on the company’s upcoming earnings report and what it might reveal about demand trends. See our latest analysis for DXP Enterprises. The recent 1 day share price decline of 7.54% and 7 day share price decline of 14.13% follow a strong year to date share price return of 37.56%. The 5 year total shareholder return of 369.37% highlights the impact of longer term...
NasdaqGS:PANW
NasdaqGS:PANWSoftware

High-Profile AI Breaches Spotlight Cyber Risk Could Be A Game Changer For Palo Alto Networks (PANW)

Palo Alto Networks recently drew heightened attention after high-profile cyber incidents, including the OpenAI and Hugging Face breaches, underscored the urgency of advanced AI-driven security solutions. This renewed focus on cyber risk highlights Palo Alto Networks’ role as a key provider of integrated, AI-enabled defenses at a time when organizations are reassessing how they protect critical data and infrastructure. Next, we’ll examine how this heightened focus on AI-driven cybersecurity...
NYSE:SUI
NYSE:SUIResidential REITs

Why Sun Communities (SUI) Is Up 6.9% After Beating Core FFO Guidance And Announcing $1B Buyback

Sun Communities, Inc. has now reported its second-quarter 2026 results, with sales of US$422.7 million and revenue of US$484.6 million, but a net loss of US$992.7 million that translated into a basic loss per share of US$8.06. Beneath the headline loss, the company delivered core funds from operations of US$1.84 per share above guidance, raised its full-year outlook, authorized a US$1 billion share repurchase program, and completed the sale of its U.K. business to concentrate on its North...
NYSE:TYL
NYSE:TYLSoftware

Tyler Technologies (TYL) Beat Q2 And Expanded Buybacks, Is The Stock Above Fair Value?

Tyler Technologies (TYL) is in focus after reporting second quarter 2026 results and updating investors on a sizable share repurchase program, providing fresh data points to assess the stock. See our latest analysis for Tyler Technologies. The earnings beat and expanded buyback plan have come after a mixed stretch for Tyler Technologies, with a 17.3% 7 day share price return and its 1 year total shareholder return down 39.87% at a recent price of $333.50. That pattern suggests short term...
NasdaqGS:CSWC
NasdaqGS:CSWCCapital Markets

What Capital Southwest (CSWC)'s Share Increase Vote and NII Guidance Reveal About Private Credit Strategy

At its 2026 Annual Meeting held on July 22, 2026, Capital Southwest Corporation’s shareholders approved adjourning the meeting to September 1, 2026 to gather additional proxies for a vote on increasing the company’s authorized common share count through a Charter Amendment. Earlier in July, Capital Southwest also released preliminary first-quarter 2026 net investment income guidance of US$0.58–US$0.59 per share, giving investors an early view of its operating performance. Against this...
NYSE:CWEN
NYSE:CWENRenewable Energy

Clearway Energy (CWEN) Faces An Earnings Test Following An Undervalued Narrative

Clearway Energy earnings expectations set the tone Clearway Energy (CWEN) is in focus as investors watch for June 2026 quarterly results, with expectations for lower earnings alongside higher revenue. These results could influence how the stock trades in the near term. See our latest analysis for Clearway Energy. Clearway Energy’s recent share price performance has been weak, with the stock down 23.74% on a 90 day share price return basis, even though the 3 year total shareholder return is...
NYSE:CE
NYSE:CEChemicals

Celanese (CE) Wins Court Relief, Is The Stock 36% Undervalued?

Why Celanese Stock Is Back In Focus After Amsterdam Court Ruling The latest move in Celanese (CE) stock action stems from a legal update. The Amsterdam District Court dismissed damages and liability claims tied to historic ethylene purchases in North-Western Europe. See our latest analysis for Celanese. For context, Celanese shares trade at US$43.93 after a 1-day share price return of 0.99%. However, the 90-day share price return declined 35.17% and the 1-year total shareholder return...
NYSE:SLB
NYSE:SLBEnergy Services

How SLB’s (SLB) Q2 2026 Revenue Guidance, Buybacks, And Dividend Have Changed Its Investment Story

In the second quarter of 2026, SLB N.V. reported higher sales of US$8,972 million but lower net income of US$786 million year-on-year, reaffirmed its quarterly dividend at US$0.295 per share, completed a US$648 million buyback tranche, and issued guidance for sequential revenue growth in the third quarter and revenue above US$10 billion in the fourth quarter of 2026. Management’s outlook for continued revenue expansion, supported by growth in digital and production systems and framed around...
NYSE:AGL
NYSE:AGLHealthcare

Agilon Health (AGL) Could Be 54% Above Fair Value As CTO Exit Raises Questions

agilon health (AGL) drew investor attention after announcing that Chief Technology Officer Girish Venkatachaliah will leave his role on August 1, 2026, and will remain as a consultant through the end of the year. See our latest analysis for agilon health. The CTO transition comes at a volatile moment for agilon health, with the share price falling 6.54% over the last day and 22.71% over the last week, yet still showing a very large year to date share price return of around 4.5x and a 94.05%...
NasdaqCM:PLUG
NasdaqCM:PLUGElectrical

Plug Power (PLUG) Launches Quantum Leap, Is The Turnaround Already Priced In?

Plug Power (PLUG) is back in focus after launching its Project Quantum Leap restructuring program and agreeing to sell its Graham, Texas hydrogen project, moves that coincide with more optimistic Wall Street earnings estimates. See our latest analysis for Plug Power. At a latest share price of US$1.90, Plug Power’s short term share price momentum has been weak, with the stock down 26.6% over 30 days and 39.3% over 90 days. However, the 1 year total shareholder return of 22.6% contrasts...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

Arrowhead Pharmaceuticals (ARWR) Could Be 3% Undervalued On Late Stage Trial Progress

Arrowhead Pharmaceuticals (ARWR) is back in focus after two late stage RNA interference programs hit important milestones. Plozasiran delivered positive Phase 3 topline data in severe hypertriglyceridemia, and zodasiran’s Phase 3 YOSEMITE trial has now completed enrollment. See our latest analysis for Arrowhead Pharmaceuticals. The recent late stage cardiometabolic data appear to be feeding into Arrowhead Pharmaceuticals’ share price momentum, with a 30 day share price return of 7.11% and a...
NasdaqGS:ABCL
NasdaqGS:ABCLLife Sciences

AbCellera Biologics (ABCL) Is Down 5.9% After Vertex-Backed T-Cell Engager Collaboration Announcement

AbCellera Biologics Inc. recently announced a collaboration with Vertex Pharmaceuticals to research, develop, manufacture, and commercialize multispecific T-cell engagers for autoimmune diseases and other conditions, with AbCellera receiving US$28 million in upfront payments plus eligibility for milestones and tiered royalties. This agreement broadens the use of AbCellera’s T-cell engager platform while allowing Vertex to fund all R&D, potentially adding a new stream of partnered, downstream...
NYSE:CUBE
NYSE:CUBESpecialized REITs

CubeSmart (CUBE) Reaffirms Its Dividend, Is The Stock Still Undervalued?

CubeSmart (CUBE) has reaffirmed its income return profile, with the Board of Trustees declaring a quarterly dividend of $0.53 per common share for the period ending September 30, 2026. See our latest analysis for CubeSmart. The reaffirmed dividend sits alongside a steady pick up in CubeSmart's share price momentum, with a 7 day share price return of 3.19% and a year to date share price return of 19.86%, while the 1 year total shareholder return is 9.09%. If CubeSmart's steady income and price...
NYSE:PCOR
NYSE:PCORSoftware

Guidewire Stock And 2 Software Picks Tied To The AI Spending Debate

Big tech’s heavy spending on artificial intelligence is suddenly under the microscope after Meta shares dropped 11% on plans to lift annual spending to as much as US$145b, even as quarterly profit fell 14% to US$6b and free cash flow slid to a five year low of US$784 million. With Google also facing questions around the pay off from high AI budgets, many investors are rethinking which companies might benefit or struggle as this theme plays out. This article looks at three business...
NasdaqGS:AGYS
NasdaqGS:AGYSSoftware

July 2026's Top Value Stocks With Estimated Discounted Prices

Over the last 7 days, the United States market has experienced a 2.6% drop, yet it remains up by 14% over the past year with earnings forecasted to grow by 17% annually. In this environment, identifying undervalued stocks can be a strategic approach for investors seeking opportunities where current prices may not fully reflect future growth potential.
NasdaqGM:RUM
NasdaqGM:RUMInteractive Media and Services

Top Growth Companies With Insider Ownership In July 2026

Over the last 7 days, the United States market has experienced a 2.6% drop, yet it remains up by 14% over the past year with earnings forecasted to grow by 17% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business and potential alignment of interests between management and shareholders.
NasdaqCM:YIBO
NasdaqCM:YIBOCommercial Services

3 Promising Penny Stocks With Market Caps Up To $200M

Over the last 7 days, the U.S. market has dropped 2.6%, but it has risen by 14% over the past year, with earnings projected to grow annually by 17% in the coming years. In light of these conditions, investors may find value in penny stocks—an investment area that still holds relevance despite being an older term. By focusing on companies with solid financials and potential for growth, investors can uncover opportunities among smaller or less-established firms that might offer both stability...
NYSE:AGM
NYSE:AGMDiversified Financial

Is Federal Agricultural Mortgage (AGM) Undervalued After Scheduling Its Q2 2026 Earnings Release?

Federal Agricultural Mortgage (AGM) is back on investors’ radar after the company scheduled its Q2 2026 earnings release and conference call for after the market close on July 30, 2026. See our latest analysis for Federal Agricultural Mortgage. The upcoming Q2 2026 earnings date lands after a strong run, with Federal Agricultural Mortgage’s 90 day share price return of 22.94% and 1 year total shareholder return of 28.38% building momentum on a 5 year total shareholder return of 165.14%. If...
NYSE:AMC
NYSE:AMCEntertainment

AMC (AMC) Is Up 22.2% After Record Revenue and IMAX Hit Spotlight Premium Format Strategy

In the second quarter of 2026, AMC Entertainment Holdings reported revenue of US$1,596.7 million, up from US$1,397.9 million a year earlier, while its net loss widened to US$11.4 million and basic loss per share from continuing operations moved to US$0.02. The company also highlighted the exceptional performance of “The Odyssey,” which delivered the strongest two-week IMAX run in history, underscoring how premium formats and sold-out high-end showtimes are becoming a critical driver of...
NYSE:BWXT
NYSE:BWXTAerospace & Defense

Is BWX Technologies (BWXT) Priced For Perfection After A 215% Run?

BWX Technologies has delivered a very strong run over the last five years, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiple checks currently point to the stock trading at a premium to those fundamentals. BWX Technologies has returned 215.2% over five years, which sets a high bar for any further upside to be supported by fundamentals. The company’s valuation can be supported by expectations for continued cash flow generation from its core defense and...
NasdaqGS:UTHR
NasdaqGS:UTHRBiotechs

Is United Therapeutics (UTHR) Undervalued After Its Phase 3 Ralinepag Results?

United Therapeutics (UTHR) stock is in focus after the company reported statistically significant phase 3 ADVANCE OUTCOMES results for its investigational PAH therapy ralinepag, with full data recently published in The Lancet. See our latest analysis for United Therapeutics. The latest ralinepag data and board appointment of Dr. Victor Dzau come as United Therapeutics trades at US$524.70, with the share price return up 5.63% year to date but the 90-day share price return down 8.16%. Over a...
NYSE:CB
NYSE:CBInsurance

Chubb (CB) Stock Looks Reasonable On Earnings While Fair Value Looks Strong

Chubb stock has delivered a strong 126.4% total return over the past 5 years, yet the current checks send a mixed message, with the Excess Returns intrinsic value estimate suggesting the shares trade at a sizeable discount while the broader valuation framework does not flag the stock as an obvious bargain. Over 5 years, Chubb has returned 126.4%, which puts recent share price strength at the center of any valuation discussion. Future expectations for underwriting quality and capital...
NYSE:HOG
NYSE:HOGAuto

Harley-Davidson (HOG) Is Down 10.1% After Earnings Drop While Buybacks Continue - What's Changed

In July 2026, Harley-Davidson, Inc. reported that second-quarter net income fell to US$79.81 million from US$107.57 million a year earlier, with first-half net income dropping to US$104.58 million from US$240.67 million, while continuing to execute its share repurchase program. Despite the weaker earnings, Harley-Davidson has completed repurchases totaling 24,470,194 shares for about US$1.33 billion since July 2024, signaling ongoing capital returns even as profitability softens. Next, we’ll...
NYSE:FMC
NYSE:FMCChemicals

FMC (FMC) Reported Lower Sales And A Loss, Is It Still 37% Undervalued?

FMC earnings jolt investor focus FMC (FMC) is in the spotlight after reporting second quarter 2026 results that showed lower sales and a move from profit to loss, alongside updated revenue guidance pointing to a full year decline. See our latest analysis for FMC. The earnings miss and lower full year revenue guidance have come alongside heavy selling in FMC, with the share price down 8.5% on the day of the report and the 1 year total shareholder return falling 74.9%. This hints at fading...